Jounce Inc. Announces Debut Of The Jounce.Com Marketing Platform
marketing by simplifying and streamlining the processes of listing, searching, finding, and recommending affiliate offers online.
"...Affiliate marketing is a great way to earn extra money or even become financially independent, but it is overly-complicated and can be extremely time-consuming. We believe that it doesn't need to be,” said Tyson Quick, CEO of Jounce. “Our goal is to simplify the entire process of finding and recommending offers on the web so that affiliates can promote and get paid more quickly."
Designed for performance marketers, Jounce combines the separated and overly-complex processes of affiliate marketing into one platform and process. It allows individual affiliate marketers to search and compare offers across multiple networks in order to find those with the highest returns without the requirement of a login or membership. Jounce provides direct access to information on offers and networks, real-time industry news, as well as the ability to retrieve individual referral links and share them via social media sites like Facebook, Twitter, or a personal blog.
“There have been no industry accepted standards, procedures, or regulations set. It has essentially been a divided and closed market where new affiliates have little or no direction of where they should start and where they should look for offers to promote, only having to wait even longer until they are accepted into a program and can actually search their limited network’s database. It's frustrating at how much effort it requires to find affiliate offers on the web today. We hope to change this.” said Kevin Mesiab, Jounce CTO.
Tools like Jounce Search gives affiliate marketers instant access to tens of millions of offers, (exponentially more than any other affiliate network with much more to come). Jounce's databases are not industry specific, but all-encompassing product and service lists. The simplicity of the service and vastness of the offer possibilities are defining advantages to the Jounce Affiliate Marketing Platform.
Besides the ability to quickly list, search, find, and promote offers, Jounce provides access to nearly every element of affiliate marketing in order for users to stay informed and successful.
These features include:
- Jounce Base
- Jounce Industry News
- Jounce Blog
- Jounce Advertising
“Our service will provide an active and cohesive community for performance marketers where information is transparent and easily accessible to everyone, from the novice affiliate to the industry leader," said Tyson. "Ultimately, we will open all of the doors and become the one stop-shop for ALL affiliate marketers.”
Jounce, headquartered in Salt Lake City, Utah, is an up-and-coming affiliate technology company that is devoted to building the most powerful and usable software applications for affiliate marketers. Its flagship product, Jounce.com, empowers users with the tools necessary to quickly find, recommend, and get paid for offers on the web.
For more information visit (www.jounce.com/about)
Jounce Video Introduction on YouTube (http://www.youtube.com/watch?v=hWiYByw4e98)
Jounce, headquartered in Salt Lake City, Utah, is an up-and-coming affiliate technology company that is devoted to building the most powerful and usable software applications for affiliate marketers. Its flagship product, Jounce.com, empowers users with the tools necessary to quickly find, recommend, and get paid for offers on the web. Jounce provides access to nearly every element of affiliate marketing in order for users to stay informed and successful.
2004 S 800 E
Salt Lake City,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Jounce Inc. Announces Debut Of The Jounce.Com Marketing Platform here
News-ID: 141296 • Views: 1663
More Releases for Jounce
Monoclonal Antibodies Therapeutics-Pipeline Analysis 2018, Clinical Trials & Res …
Monoclonal antibodies are the prominent therapeutic agents in biomedical research, as they are implemented in the diagnosis and treatment of various diseases areas, including cancer, infectious diseases, immunology, and cardiovascular disorders. The antibodies are produced from cell lines, which are obtained from the immunized animals. The animals are immunized with the substance that is being studied. Download the sample report at: https://www.pharmaproff.com/request-sample/1186 After that, the fusion of immunized animal’s myeloma cells
Hepatitis A Virus Cellular Receptor 2 Market Research Report 2019-2025 | Top Key …
UpMarketResearch offers a latest published report on “Global Hepatitis A Virus Cellular Receptor 2 Market Analysis and Forecast 2019-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 114 which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/50129 Hepatitis A Virus Cellular Receptor
Global Bispecific Antibody Market, Drug Sales and Clinical Pipeline Insight 2025
" Global Bispecific Antibody Market, Drug Sales and Clinical Pipeline Insight 2025" Report Highlights: Applications of Bispecific Antibodies Global Bispecific Antibody Market Overview: Drug and Market Sales Global Bispecific Antibody Market Opportunity: US$ 8 Billion by 2025 US and Japan Market Share Opportunity: andgt;40% by 2025 Bispecific Antibody Clinical Pipeline: 224 Drugs Commercially Available Bispecific Antibody: 2 (HEMLIBRA and Blincyto) The research and development of bispecific antibodies has emerged as a new
Hepatitis A Virus Cellular Receptor 2, (H1 2018) Pipeline Review Studied and Ana …
HAVCR2 is Th1 specific, responsible for controlling macrophage activation and alloimmune responses. Binding of Hepatitis A Virus Cellular Receptor 2, also known as HAVCR2 to lgals9 may result in cancers depending on the expression of lgals9 gene in the body. In its recently added report titled, ‘Hepatitis A Virus Cellular Receptor 2, HAVCR2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T
Nov 7, 2017: Polyvalent Double Specificity Antibodies Market Forecast 2023 Bayer …
Polyvalent Double Specificity Antibodies Market Research 2017 A market study ” Global Polyvalent Double Specificity Antibodies Market ” examines the performance of the Polyvalent Double Specificity Antibodies market 2017. It encloses an in-depth Research of the Polyvalent Double Specificity Antibodies market state and the competitive landscape globally. This report analyzes the potential of Polyvalent Double Specificity Antibodies market in the present and the future prospects from various angles in detail. The Global
Global Bispecific Antibody Market Research Report Forecast 2017 to 2021Global Bi …
Report Hive Market Research Released a New Research Report of 119 pages on Title " Global Bispecific Antibody Market Research Report Forecast 2017 to 2021 "with detailed Analysis, Forecast and Strategies. The Global Bispecific Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Bispecific Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as